LMW Heparin Market Forecast to 2028 - COVID-19 Impact and Global Analysis by Product Type (Enoxaparin, Dalteparin, Tinzaparin, Fraxiparine); Application (Treatment of Venous Thromboembolism, Complications of Pregnancy, Cardioversion of Atrial Fibrillation/Flutter, Others) and Geography

Report Code: TIPRE00012951 | No. of Pages: 150 | Category: Pharmaceuticals | Status: Upcoming

Covid
Assesing the covid-19 impact?
Get the Latest COVID-19 Analysis on this market
Request Now
Happy to join you in your fight against the COVID-19 economic pandemic!
MARKET INTRODUCTION

Low molecular weight heparin is basically derived from unfractionated heparin with an average molecular weight containing less than 8,000 Da. Low molecular weight heparins are extracted mainly by enzymatic or chemical depolymerization from unfractionated heparin. Low molecular weight heparin contains fewer side effects as compared to unfractionated heparins, which further involve lesser risk of heparin-induced osteopenia along with heparin-induced thrombocytopenia (HIT). Currently, low molecular weight heparin has the standard of care drugs and is widely utilized for the treatment and prophylaxis of arterial as well as venous thrombosis. Dose consideration for low molecular weight heparin depends on a patient's weight.

MARKET DYNAMICS

The LMW heparin market has witnessed a significant growth owing to factors such as wider application in the treatment of venous thromboembolism, complications of pregnancy, cardioversion of atrial fibrillation/flutter, and others. Proven health benefits of low molecular weight heparin over the unfractionated heparin are boosting the demand for low molecular weight heparin across the globe, which in turn is fuelling the growth of this market. The rise in demand for low molecular weight heparin is anticipated to grow exponentially in the near future due to increasing usage in surgeries along with the treatment of coagulation disorders. However, lack of its ability to reverse mainly the effect of overdose resulting in the development of HIT as well as other bleeding disorders restrains the growth of the low molecular weight heparin market. Nevertheless, with the steady growth in the healthcare industry and biomedical sector, there are opportunities for the market players to invest in this market.

MARKET SCOPE

The "Global LMW Heparin Market Analysis to 2028” is a specialized and in-depth study of the healthcare industry with a special focus on the global market trend analysis. The report aims to provide an overview of the LMW heparin market with detailed market segmentation by product type, application, and geography. The global LMW heparin market is expected to witness high growth during the forecast period. The report provides key statistics on the market status of the leading LMW heparin market players and offers key trends and opportunities in the market.

MARKET SEGMENTATION

The global LMW heparin market is segmented on the basis of product type, and application. On the basis of product type, the LMW heparin market is segmented into enoxaparin, dalteparin, tinzaparin, and fraxiparine. The LMW heparin market on the basis of the application is classified into treatment of venous thromboembolism, complications of pregnancy, cardioversion of atrial fibrillation/flutter, and others.

REGIONAL FRAMEWORK

The report provides a detailed overview of the industry including both qualitative and quantitative information. It provides an overview and forecast of the global LMW heparin market based on various segments. It also provides market size and forecast estimates from the year 2020 to 2028 with respect to five major regions, namely; North America, Europe, Asia-Pacific (APAC), Middle East and Africa (MEA) and South America. The LMW heparin market by each region is later sub-segmented by respective countries and segments. The report covers the analysis and forecast of 18 countries globally along with the current trend and opportunities prevailing in the region.
The report analyzes factors affecting the LMW heparin market from both demand and supply side and further evaluates market dynamics affecting the market during the forecast period i.e., drivers, restraints, opportunities, and future trend. The report also provides exhaustive PEST analysis for all five regions namely; North America, Europe, APAC, MEA, and South America after evaluating political, economic, social and technological factors affecting the LMW heparin market in these regions.



Get more information on this report :

MARKET PLAYERS


The reports cover various key developments in the global LMW heparin market. Various companies are focusing growth strategies such as product launches, product approvals and others such as patents and events. Some of the growth strategies activities witnessed in the market were acquisitions, and partnership & collaborations. These activities have paved way for the expansion of business and customer base of market players. The market payers from LMW heparin market are anticipated to lucrative growth opportunities in the future with the rising demand for LMW heparin in the global market. Below mentioned is the list of few companies engaged in the LMW heparin market.
The report also includes the profiles of key companies along with their SWOT analysis and market strategies in the LMW heparin market. In addition, the report focuses on leading industry players with information such as company profiles, components, and services offered, financial information of the last 3 years, the key development in the past five years.

  •   Aspen
  •   Changzhou Qianhong Bio-pharma
  •   CSBIO
  •   Dongying Tiandong Pharmaceutical
  •   Opocrin
  •   Pfizer
  •   Sanofi-aventis
  •   Techdow
  •   Yantai Dongcheng Pharmaceutical Group
  •   Others

The Insight Partner's dedicated research and analysis team consist of experienced professionals with advanced statistical expertise and offer various customization options in the existing study.


Get more information on this report :

TABLE OF CONTENTS

1. INTRODUCTION
1.1. SCOPE OF THE STUDY
1.2. THE INSIGHT PARTNERS RESEARCH REPORT GUIDANCE
1.3. MARKET SEGMENTATION
1.3.1 LMW Heparin Market - By Product Type
1.3.2 LMW Heparin Market - By Application
1.3.3 LMW Heparin Market - By Region
1.3.3.1 By Country

2. KEY TAKEAWAYS

3. RESEARCH METHODOLOGY

4. LMW HEPARIN MARKET LANDSCAPE
4.1. OVERVIEW
4.2. PORTER’S FIVE FORCES ANALYSIS
4.2.1 Bargaining Power of Buyers
4.2.1 Bargaining Power of Suppliers
4.2.1 Threat of Substitute
4.2.1 Threat of New Entrants
4.2.1 Competitive Rivalry
4.3. EXPERT OPINIONS

5. LMW HEPARIN MARKET - KEY MARKET DYNAMICS
5.1. KEY MARKET DRIVERS
5.2. KEY MARKET RESTRAINTS
5.3. KEY MARKET OPPORTUNITIES
5.4. FUTURE TRENDS
5.5. IMPACT ANALYSIS OF DRIVERS AND RESTRAINTS

6. LMW HEPARIN MARKET - GLOBAL MARKET ANALYSIS
6.1. LMW HEPARIN - GLOBAL MARKET OVERVIEW
6.2. LMW HEPARIN - GLOBAL MARKET AND FORECAST TO 2028
6.3. MARKET POSITIONING/MARKET SHARE

7. LMW HEPARIN MARKET - REVENUE AND FORECASTS TO 2028 – PRODUCT TYPE
7.1. OVERVIEW
7.2. PRODUCT TYPE MARKET FORECASTS AND ANALYSIS
7.3. ENOXAPARIN
7.3.1. Overview
7.3.2. Enoxaparin Market Forecast and Analysis
7.4. DALTEPARIN
7.4.1. Overview
7.4.2. Dalteparin Market Forecast and Analysis
7.5. TINZAPARIN
7.5.1. Overview
7.5.2. Tinzaparin Market Forecast and Analysis
7.6. FRAXIPARINE
7.6.1. Overview
7.6.2. Fraxiparine Market Forecast and Analysis
8. LMW HEPARIN MARKET - REVENUE AND FORECASTS TO 2028 – APPLICATION
8.1. OVERVIEW
8.2. APPLICATION MARKET FORECASTS AND ANALYSIS
8.3. TREATMENT OF VENOUS THROMBOEMBOLISM
8.3.1. Overview
8.3.2. Treatment of Venous Thromboembolism Market Forecast and Analysis
8.4. COMPLICATIONS OF PREGNANCY
8.4.1. Overview
8.4.2. Complications of Pregnancy Market Forecast and Analysis
8.5. CARDIOVERSION OF ATRIAL FIBRILLATION/FLUTTER
8.5.1. Overview
8.5.2. Cardioversion of Atrial Fibrillation/Flutter Market Forecast and Analysis
8.6. OTHERS
8.6.1. Overview
8.6.2. Others Market Forecast and Analysis

9. LMW HEPARIN MARKET REVENUE AND FORECASTS TO 2028 – GEOGRAPHICAL ANALYSIS
9.1. NORTH AMERICA
9.1.1 North America LMW Heparin Market Overview
9.1.2 North America LMW Heparin Market Forecasts and Analysis
9.1.3 North America LMW Heparin Market Forecasts and Analysis - By Product Type
9.1.4 North America LMW Heparin Market Forecasts and Analysis - By Application
9.1.5 North America LMW Heparin Market Forecasts and Analysis - By Countries
9.1.5.1 United States LMW Heparin Market
9.1.5.1.1 United States LMW Heparin Market by Product Type
9.1.5.1.2 United States LMW Heparin Market by Application
9.1.5.2 Canada LMW Heparin Market
9.1.5.2.1 Canada LMW Heparin Market by Product Type
9.1.5.2.2 Canada LMW Heparin Market by Application
9.1.5.3 Mexico LMW Heparin Market
9.1.5.3.1 Mexico LMW Heparin Market by Product Type
9.1.5.3.2 Mexico LMW Heparin Market by Application
9.2. EUROPE
9.2.1 Europe LMW Heparin Market Overview
9.2.2 Europe LMW Heparin Market Forecasts and Analysis
9.2.3 Europe LMW Heparin Market Forecasts and Analysis - By Product Type
9.2.4 Europe LMW Heparin Market Forecasts and Analysis - By Application
9.2.5 Europe LMW Heparin Market Forecasts and Analysis - By Countries
9.2.5.1 Germany LMW Heparin Market
9.2.5.1.1 Germany LMW Heparin Market by Product Type
9.2.5.1.2 Germany LMW Heparin Market by Application
9.2.5.2 France LMW Heparin Market
9.2.5.2.1 France LMW Heparin Market by Product Type
9.2.5.2.2 France LMW Heparin Market by Application
9.2.5.3 Italy LMW Heparin Market
9.2.5.3.1 Italy LMW Heparin Market by Product Type
9.2.5.3.2 Italy LMW Heparin Market by Application
9.2.5.4 United Kingdom LMW Heparin Market
9.2.5.4.1 United Kingdom LMW Heparin Market by Product Type
9.2.5.4.2 United Kingdom LMW Heparin Market by Application
9.2.5.5 Russia LMW Heparin Market
9.2.5.5.1 Russia LMW Heparin Market by Product Type
9.2.5.5.2 Russia LMW Heparin Market by Application
9.2.5.6 Rest of Europe LMW Heparin Market
9.2.5.6.1 Rest of Europe LMW Heparin Market by Product Type
9.2.5.6.2 Rest of Europe LMW Heparin Market by Application
9.3. ASIA-PACIFIC
9.3.1 Asia-Pacific LMW Heparin Market Overview
9.3.2 Asia-Pacific LMW Heparin Market Forecasts and Analysis
9.3.3 Asia-Pacific LMW Heparin Market Forecasts and Analysis - By Product Type
9.3.4 Asia-Pacific LMW Heparin Market Forecasts and Analysis - By Application
9.3.5 Asia-Pacific LMW Heparin Market Forecasts and Analysis - By Countries
9.3.5.1 Australia LMW Heparin Market
9.3.5.1.1 Australia LMW Heparin Market by Product Type
9.3.5.1.2 Australia LMW Heparin Market by Application
9.3.5.2 China LMW Heparin Market
9.3.5.2.1 China LMW Heparin Market by Product Type
9.3.5.2.2 China LMW Heparin Market by Application
9.3.5.3 India LMW Heparin Market
9.3.5.3.1 India LMW Heparin Market by Product Type
9.3.5.3.2 India LMW Heparin Market by Application
9.3.5.4 Japan LMW Heparin Market
9.3.5.4.1 Japan LMW Heparin Market by Product Type
9.3.5.4.2 Japan LMW Heparin Market by Application
9.3.5.5 South Korea LMW Heparin Market
9.3.5.5.1 South Korea LMW Heparin Market by Product Type
9.3.5.5.2 South Korea LMW Heparin Market by Application
9.3.5.6 Rest of Asia-Pacific LMW Heparin Market
9.3.5.6.1 Rest of Asia-Pacific LMW Heparin Market by Product Type
9.3.5.6.2 Rest of Asia-Pacific LMW Heparin Market by Application
9.4. MIDDLE EAST AND AFRICA
9.4.1 Middle East and Africa LMW Heparin Market Overview
9.4.2 Middle East and Africa LMW Heparin Market Forecasts and Analysis
9.4.3 Middle East and Africa LMW Heparin Market Forecasts and Analysis - By Product Type
9.4.4 Middle East and Africa LMW Heparin Market Forecasts and Analysis - By Application
9.4.5 Middle East and Africa LMW Heparin Market Forecasts and Analysis - By Countries
9.4.5.1 South Africa LMW Heparin Market
9.4.5.1.1 South Africa LMW Heparin Market by Product Type
9.4.5.1.2 South Africa LMW Heparin Market by Application
9.4.5.2 Saudi Arabia LMW Heparin Market
9.4.5.2.1 Saudi Arabia LMW Heparin Market by Product Type
9.4.5.2.2 Saudi Arabia LMW Heparin Market by Application
9.4.5.3 U.A.E LMW Heparin Market
9.4.5.3.1 U.A.E LMW Heparin Market by Product Type
9.4.5.3.2 U.A.E LMW Heparin Market by Application
9.4.5.4 Rest of Middle East and Africa LMW Heparin Market
9.4.5.4.1 Rest of Middle East and Africa LMW Heparin Market by Product Type
9.4.5.4.2 Rest of Middle East and Africa LMW Heparin Market by Application
9.5. SOUTH AND CENTRAL AMERICA
9.5.1 South and Central America LMW Heparin Market Overview
9.5.2 South and Central America LMW Heparin Market Forecasts and Analysis
9.5.3 South and Central America LMW Heparin Market Forecasts and Analysis - By Product Type
9.5.4 South and Central America LMW Heparin Market Forecasts and Analysis - By Application
9.5.5 South and Central America LMW Heparin Market Forecasts and Analysis - By Countries
9.5.5.1 Brazil LMW Heparin Market
9.5.5.1.1 Brazil LMW Heparin Market by Product Type
9.5.5.1.2 Brazil LMW Heparin Market by Application
9.5.5.2 Argentina LMW Heparin Market
9.5.5.2.1 Argentina LMW Heparin Market by Product Type
9.5.5.2.2 Argentina LMW Heparin Market by Application
9.5.5.3 Rest of South and Central America LMW Heparin Market
9.5.5.3.1 Rest of South and Central America LMW Heparin Market by Product Type
9.5.5.3.2 Rest of South and Central America LMW Heparin Market by Application

10. INDUSTRY LANDSCAPE
10.1. MERGERS AND ACQUISITIONS
10.2. AGREEMENTS, COLLABORATIONS AND JOIN VENTURES
10.3. NEW PRODUCT LAUNCHES
10.4. EXPANSIONS AND OTHER STRATEGIC DEVELOPMENTS

11. LMW HEPARIN MARKET, KEY COMPANY PROFILES
11.1. ASPEN
11.1.1. Key Facts
11.1.2. Business Description
11.1.3. Products and Services
11.1.4. Financial Overview
11.1.5. SWOT Analysis
11.1.6. Key Developments
11.2. CHANGZHOU QIANHONG BIO-PHARMA
11.2.1. Key Facts
11.2.2. Business Description
11.2.3. Products and Services
11.2.4. Financial Overview
11.2.5. SWOT Analysis
11.2.6. Key Developments
11.3. CSBIO
11.3.1. Key Facts
11.3.2. Business Description
11.3.3. Products and Services
11.3.4. Financial Overview
11.3.5. SWOT Analysis
11.3.6. Key Developments
11.4. DONGYING TIANDONG PHARMACEUTICAL
11.4.1. Key Facts
11.4.2. Business Description
11.4.3. Products and Services
11.4.4. Financial Overview
11.4.5. SWOT Analysis
11.4.6. Key Developments
11.5. OPOCRIN
11.5.1. Key Facts
11.5.2. Business Description
11.5.3. Products and Services
11.5.4. Financial Overview
11.5.5. SWOT Analysis
11.5.6. Key Developments
11.6. PFIZER
11.6.1. Key Facts
11.6.2. Business Description
11.6.3. Products and Services
11.6.4. Financial Overview
11.6.5. SWOT Analysis
11.6.6. Key Developments
11.7. SANOFI-AVENTIS
11.7.1. Key Facts
11.7.2. Business Description
11.7.3. Products and Services
11.7.4. Financial Overview
11.7.5. SWOT Analysis
11.7.6. Key Developments
11.8. TECHDOW
11.8.1. Key Facts
11.8.2. Business Description
11.8.3. Products and Services
11.8.4. Financial Overview
11.8.5. SWOT Analysis
11.8.6. Key Developments
11.9. YANTAI DONGCHENG PHARMACEUTICAL GROUP
11.9.1. Key Facts
11.9.2. Business Description
11.9.3. Products and Services
11.9.4. Financial Overview
11.9.5. SWOT Analysis
11.9.6. Key Developments
11.10. OTHERS
11.10.1. Key Facts
11.10.2. Business Description
11.10.3. Products and Services
11.10.4. Financial Overview
11.10.5. SWOT Analysis
11.10.6. Key Developments

12. APPENDIX
12.1. ABOUT THE INSIGHT PARTNERS
12.2. GLOSSARY OF TERMS
The List of Companies

1. Aspen
2. Changzhou Qianhong Bio-pharma
3. CSBIO
4. Dongying Tiandong Pharmaceutical
5. Opocrin
6. Pfizer
7. Sanofi-aventis
8. Techdow
9. Yantai Dongcheng Pharmaceutical Group
10. Others
TIPRE00012951
Your data will never be shared with third parties, however, we may send you information from time to time about our products that may be of interest to you. By submitting your details, you agree to be contacted by us. You may contact us at any time to opt-out.

Pricing

Free

20%

customization on Pre-Booking